Nephrotic Syndrome Disease

BASICS

DESCRIPTION
A syndrome comprising glomerular proteinuria (3.5 g per 1.73m2 body-surface area/day), hypoalbuminemia, lipiduria, hypercholesterolemia and edema as a result of a primary renal disease or secondary to another disease process.
  • System(s) affected: Renal/Urologic, Endocrine/Metabolic
  • Genetics: N/A
  • Incidence/Prevalence in USA:
    • Children - 2:100,000 new cases/year
    • Adults - 3:100,000 new cases/year
  • Predominant age:
    • Children - 1.5-6 years (MCD)
    • Adults - all ages (FGS, MGN more common USA; IgG-IgA worldwide)
  • Predominant sex: Male = Female
SIGNS AND SYMPTOMS
  • Fluid retention: abdominal distention, ascites, edema, puffy eyelids, scrotal swelling, weight gain, shortness of breath
  • Anorexia
  • Hypertension
  • Oliguria
  • Orthostatic hypotension
  • Retinal sheen
  • Skin striae
CAUSES
  • Primary renal disease
    • Fibrillary glomerulopathy (primary)
    • Focal glomerulonephritis
    • Focal glomerulosclerosis (FGS)
    • IgA nephropathy
    • Membranoproliferative glomerulonephritis (MPGN)
    • Membranous glomerulonephritis (MGN)
    • Mesangial proliferative glomerulonephritis
    • Minimal change disease (MCD)
    • Rapidly progressive glomerulonephritis (RPGN)
    • Congenital nephrotic syndrome
  • Secondary renal disease. Associated primary renal disease shown in brackets:
    • Allergens (snake venoms, antitoxins, poison ivy, insect stings)
    • Carcinoma (bronchogenic, breast, colon, stomach, kidney) [MGN, etc]
    • Diabetes mellitus (most common)
    • Erythema multiforme
    • Fibrillary glomerulopathy (secondary: amyloid, cryoglobulins, multiple myeloma, chronic lymphocytic leukemia [CLL])
    • Henoch-Schönlein purpura
    • Heredofamilial (Alport's syndrome, Fabry's disease)
    • HIV infection
    • Hodgkin's lymphoma [MCD]
    • Infections : Ventriculoatrial shunt infection, Bacterial endocarditis [MPGN], Viral (hepatitis B [MPGN, mesangial, MGN]) Other viral (hepatitis C), protozoal and helminthic
    • Leukemias
    • Lymphomas [MGN]
    • Non-Hodgkin's lymphoma
    • Focal glomerulosclerosis (Reflux nephropathy, Heroin abuse, Nephron ablation, Extensive glomerular scarring in acute glomerulonephritis, Chronic renal allograft rejection, End-stage kidney, Morbid obesity, A thromboembolism)
    • Malignant hypertension
    • Melanoma
    • Nephrotoxins and drugs (gold, penicillamine, mercury [MGN])
    • Nonsteroidal anti-inflammatory drug induced nephrotic syndrome [MCD] and interstitial nephritis
    • Polyarteritis nodosa
    • Post-streptococcal glomerulonephritis [PSGN] - 20% are nephrotic
    • Sarcoid
    • Serum sickness
    • Sjögren's syndrome
    • Systemic lupus erythematosus (SLE) [MGN, FGS, focal, mesangial, diffuse, proliferative]
    • Toxemia of pregnancy
RISK FACTORS
  • Drug addiction (e.g., heroin [FGS])
  • Hepatitis B and C, HIV, other infections
  • Immunosuppression
  • Nephrotoxic drugs
  • Vesicoureteral reflux [FGS]
  • Cancer (usually MGN, may be nil disease [MCD])
  • Chronic analgesic abuse

DIAGNOSIS

LABORATORY
  • Hypoalbuminemia
  • Hyperlipidemia
  • Lipiduria
  • Low complement in some diseases
  • Azotemia
  • Hypercholesterolemia
  • Increased serum beta-globulin
  • Increased serum IgG
  • Urine
    • Proteinuria (> 3 gm/24 hr)
    • Glycosuria
    • Hematuria
    • Aminoaciduria
    • RBC casts
    • Granular casts
    • Proteinuria
    • Hyaline casts
    • Fatty casts
    • Foamy appearance

Drugs that may alter lab results: See description
Disorders that may alter lab results: Many

PATHOLOGICAL FINDINGS
  • Light microscopy
    • May see nothing (e.g., MCD)
    • Disease specific: sclerosis (e.g., FGS in diabetes)
  • Immunofluorescence : Mesangial IgA (Schönlein-Henoch, IgG-IgA nephropathy). Other patterns specific for disease
  • Electron microscopy (Specific for disease, e.g., sub-epithelial deposits of IgG in MGN
SPECIAL TESTS
  • Complement levels
  • Antinuclear antibody (ANA)
  • Serum protein electrophoresis / quantitative immunoglobulins
  • Urine immune electrophoresis
  • Blood cultures
  • Renal venogram for thrombosis
IMAGING
  • X-ray
  • Ultrasound
  • CT
  • MRI or venography for renal vein thrombosis
DIAGNOSTIC PROCEDURES
History, physical, basic laboratory including electrolytes, renal biopsy with light, immunofluorescence, electron microscopy for definitive diagnosis

TREATMENT

APPROPRIATE HEALTH CARE

Outpatient

GENERAL MEASURES
  • Treat infections vigorously (especially bacteriuria, endocarditis, peritonitis)
  • Anticoagulant therapy (heparin and warfarin) if thromboses occur
  • Vaccinations: pneumococcal, influenza, and Haemophilus influenzae
  • Avoid excess sunlight
  • Avoid nephrotoxic drugs
  • Judicious use of diuretics
  • Severe anemia may be treated with erythropoietin
SURGICAL MEASURES

N/A

ACTIVITY

Bedrest as tolerated

DIET
  • Normal protein intake: 1 g/kg/day
  • Low fat diet (to control cholesterol)
  • Reduced sodium intake
  • Liberal potassium intake (unless hyperkalemic)
  • Supplemental multivitamins and minerals, especially vitamin D and iron
  • Fluid restriction if hyponatremic
  • Caloric restriction if obese or diabetic
  • For hypercholesterolemia: low-fat soy-protein diet, 7 g protein/kg/day
PATIENT EDUCATION
  • Printed material for patients: National Kidney Foundation, 30 E. 33rd Street, Suite 1100, NY, NY 10016, (800)622-9010
    • "Childhood Nephrotic Syndrome" (Order #02-23NN)
    • "Diabetes and Kidney Disease" (Order #02-09CP) and "Focal Glomerulosclerosis" (Order #02-28NN)

FOLLOW UP

PREVENTION/AVOIDANCE
  • Avoid causative factors whenever possible
  • Detect and treat infections vigorously. Infections may involve the common (Pneumococcus) to the unusual (Strongyloides), especially with immunosuppression.
POSSIBLE COMPLICATIONS
  • Low levels of: 25-hydroxycholecalciferol, serum calcium, adrenocortical hormones, thyroid hormones
  • Hypercoagulability, thrombosis
  • Pulmonary emboli
  • Hyperlipidemia/accelerated cardiovascular disease
  • Acute renal failure
  • Progressive renal failure
  • Renal vein thrombosis
  • Protein malnutrition
  • Infection
  • Pleural effusion
  • Ascites
  • Iron deficiency (uncommon)
EXPECTED COURSE AND PROGNOSIS

Varies with specific causes. Complete remission expected if basic disease is treatable (infection, malignancy, drug-induced). Otherwise may progress to dialysis dependence (e.g., diabetic glomerulosclerosis).

MISCELLANEOUS

ASSOCIATED CONDITIONS
  • Cancer
  • Diabetes mellitus
  • Connective tissue disease (e.g., SLE)
  • Multiple myeloma
AGE-RELATED FACTORS

Pediatric: Relatively common in children aged 1.5-4 years (MCD)
Geriatric: Occurs in this age group. Prognosis is worse.
Others: N/A

PREGNANCY

Toxemia of pregnancy may be nephrotic

OTHER NOTES

N/A

ABBREVIATIONS
  • FGS = focal segmental glomerulosclerosis
  • MGN = membranous nephropathy
  • MPGN = chronic hypocomplementemic glomerulonephritis, chronic mesangiocapillary glomerulonephritis
  • MCD = lipid nephrosis, four process disease, nil disease
  • RPGN = crescentic glomerulonephritis
Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.